VWF-ADAMTS13 imbalance bridges infection to stroke.
作者信息
Dong Jing-Fei, Han Cha
机构信息
Bloodworks Research Institute, Seattle, WA.
Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.
出版信息
Blood Adv. 2025 Mar 25;9(6):1342-1343. doi: 10.1182/bloodadvances.2024015665.
Abstract
摘要
相似文献
1
VWF-ADAMTS13 imbalance bridges infection to stroke.血管性血友病因子-凝血酶原酶解素13失衡将感染与中风联系起来。
Blood Adv. 2025 Mar 25;9(6):1342-1343. doi: 10.1182/bloodadvances.2024015665.
2
The Role of the VWF/ADAMTS13 Axis in the Thromboinflammatory Response in Ischemic Stroke After SARS-CoV2 Infection.血管性血友病因子/凝血酶原酶-13轴在SARS-CoV2感染后缺血性卒中血栓炎症反应中的作用
Brain Behav. 2025 Feb;15(2):e70348. doi: 10.1002/brb3.70348.
3
Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke.血管性血友病因子（VWF）-含血小板结合蛋白基序的解聚蛋白样金属蛋白酶13（ADAMTS13）轴失衡导致先前呼吸道感染对中风产生有害影响。
Blood Adv. 2025 Mar 25;9(6):1330-1341. doi: 10.1182/bloodadvances.2024014622.
4
Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease.急性和慢性脑血管疾病患者中ADAMTS13水平降低。
PLoS One. 2017 Jun 7;12(6):e0179258. doi: 10.1371/journal.pone.0179258. eCollection 2017.
5
VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure.血管性血友病因子/解整合素金属蛋白酶 13 失衡与急性肝衰竭的预后和出血相关，但与整体凝血或纤溶无关。
Hepatology. 2021 May;73(5):1882-1891. doi: 10.1002/hep.31507.
6
Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke.短暂性脑缺血发作（TIA）或缺血性卒中后早期和晚期ADAMTS13活性、血管性血友病因子抗原水平与血小板功能之间的关系。
J Neurol Sci. 2015 Jan 15;348(1-2):35-40. doi: 10.1016/j.jns.2014.10.035. Epub 2014 Oct 31.
7
ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability.ADAMTS13、血管性血友病因子（VWF）和内毒素相互关联，并通过高凝状态与肝硬化的严重程度相关。
J Clin Med. 2022 Mar 26;11(7):1835. doi: 10.3390/jcm11071835.
8
von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy.在 TIA 或缺血性脑卒中患者中改变抗血小板治疗时的血管性血友病因子抗原、血管性血友病因子前肽和 ADAMTS13 活性。
J Neurol Sci. 2024 Aug 15;463:123118. doi: 10.1016/j.jns.2024.123118. Epub 2024 Jul 2.
9
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women.高 VWF、低 ADAMTS13 和口服避孕药会增加年轻女性发生缺血性卒中和心肌梗死的风险。
Blood. 2012 Feb 9;119(6):1555-60. doi: 10.1182/blood-2011-09-380618. Epub 2011 Nov 22.
10
von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.血管性血友病因子裂解蛋白酶ADAMTS13减轻实验性中风中的缺血性脑损伤。
Blood. 2009 Oct 8;114(15):3329-34. doi: 10.1182/blood-2009-03-213264. Epub 2009 Aug 17.
引用本文的文献
1
Perioperative Profiling of a Disintegrin and Metalloprotease with Thrombospondin Type 1 Motif, Member 13 (ADAMTS13) Activity in Cardiac Surgery: Kinetics and Mechanistic Insights.心脏手术中具有血小板反应蛋白基序的解聚素和金属蛋白酶13（ADAMTS13）活性的围手术期分析：动力学和机制洞察
J Clin Med. 2025 Jul 11;14(14):4936. doi: 10.3390/jcm14144936.
本文引用的文献
1
Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke.血管性血友病因子（VWF）-含血小板结合蛋白基序的解聚蛋白样金属蛋白酶13（ADAMTS13）轴失衡导致先前呼吸道感染对中风产生有害影响。
Blood Adv. 2025 Mar 25;9(6):1330-1341. doi: 10.1182/bloodadvances.2024014622.
2
Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study.血管性血友病因子与 ADAMTS-13 随增龄的动态和功能联系：社区动脉粥样硬化风险研究。
J Thromb Haemost. 2023 Dec;21(12):3371-3382. doi: 10.1016/j.jtha.2023.07.023. Epub 2023 Aug 12.
3
Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.感染作为卒中的危险因素及卒中后结局的决定因素。
Stroke. 2020 Oct;51(10):3156-3168. doi: 10.1161/STROKEAHA.120.030429. Epub 2020 Sep 8.
4
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.COVID-19 和凝血：SARS-CoV-2 感染的出血和血栓形成表现。
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
5
Inflammation, von Willebrand factor, and ADAMTS13.炎症、血管性血友病因子和 ADAMTS13。
Blood. 2018 Jul 12;132(2):141-147. doi: 10.1182/blood-2018-02-769000. Epub 2018 Jun 4.
6
Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage.内皮细胞 ADAMTS-13 和 VWF：产生、释放和 VWF 多聚体裂解。
Blood. 2009 Dec 3;114(24):5102-11. doi: 10.1182/blood-2009-07-231597. Epub 2009 Oct 12.
7
Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.志贺毒素在基因易感的ADAMTS13缺陷小鼠中引发血栓性血小板减少性紫癜。
J Clin Invest. 2005 Oct;115(10):2752-61. doi: 10.1172/JCI26007.
8
Localization of ADAMTS13 to the stellate cells of human liver.ADAMTS13在人肝脏星状细胞中的定位。
Blood. 2005 Aug 1;106(3):922-4. doi: 10.1182/blood-2005-01-0152. Epub 2005 Apr 26.
9
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow.炎症细胞因子对流动状态下内皮细胞衍生的超大血管性血友病因子多聚体释放及裂解的影响。
Blood. 2004 Jul 1;104(1):100-6. doi: 10.1182/blood-2004-01-0107. Epub 2004 Mar 16.
10
Biochemistry and genetics of von Willebrand factor.血管性血友病因子的生物化学与遗传学
Annu Rev Biochem. 1998;67:395-424. doi: 10.1146/annurev.biochem.67.1.395.
Zotero 插件